Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-arm Phase IIB Randomised, Double Blind Placebo-controlled Clinical Trial Comparing the Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis.

NCT01910259 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01910259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01910259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-arm Phase IIB Randomised, Double Blind Placebo-controlled Clinical Trial Comparing the Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis.
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Completed
Start date
December 18, 2014
Completion date
July 4, 2018
Enrollment
445 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

secondary progressive multiple sclerosis